Role of FDG PET, CT, and Bone Marrow Biopsy (2011 ASH Conference)


The revised response criteria for malignant lymphoma incorporated FDG PET for determination of response.

Chief of the Lymphoma Service Andrew Zelenetz discusses a retrospective review performed to understand the frequency of FDG avidity across a range of lymphoma histologies and to compare diagnostic yield to CT. Diagnostic utility of bone marrow biopsy was also evaluated.